当前位置:
X-MOL 学术
›
Eur. J. Heart Fail.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2022-07-01 , DOI: 10.1002/ejhf.2596 Bojan Vrtovec 1 , Sabina Frljak 1 , Gregor Poglajen 1 , Gregor Zemljic 1 , Andraz Cerar 1 , Matjaz Sever 2 , Francois Haddad 3 , Joseph C Wu 3
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2022-07-01 , DOI: 10.1002/ejhf.2596 Bojan Vrtovec 1 , Sabina Frljak 1 , Gregor Poglajen 1 , Gregor Zemljic 1 , Andraz Cerar 1 , Matjaz Sever 2 , Francois Haddad 3 , Joseph C Wu 3
Affiliation
We investigated the effects of CD34+ cell therapy in patients with heart failure with preserved ejection fraction (HFpEF).
中文翻译:
细胞疗法治疗射血分数保留心力衰竭的临床试验
我们研究了 CD34 +细胞治疗对射血分数保留的心力衰竭 (HFpEF) 患者的影响。
更新日期:2022-07-01
中文翻译:
细胞疗法治疗射血分数保留心力衰竭的临床试验
我们研究了 CD34 +细胞治疗对射血分数保留的心力衰竭 (HFpEF) 患者的影响。